+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Analgesics in Norway

  • ID: 227076
  • Report
  • Region: Norway
  • 23 pages
  • Euromonitor International
1 of 2
Norwegian doctors are increasingly prescribing acetaminophen for their patients, leading to a proportional decline in the usage of OTC acetaminophen in relation to the total usage of acetaminophen. This prevented the higher growth of analgesics, as the demand for OTC acetaminophen was lower than it would have been without the increase in prescriptions. Furthermore, other analgesics categories are relatively mature, such as adult ibuprofen, aspirin, naproxen and diclofenac.

The author's Analgesics in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 2
Analgesics in Norway

List of Contents and Tables
Headlines
Prospects
Rise in Prescription Analgesics Impacts Growth
Topical Analgesics/anaesthetic Benefiting From Rise in Muscle and Skeletal Problems
Side Effects of Diclofenac Sees Consumers Switching To Acetaminophen
Competitive Landscape
Well-known Products Take Preference Among Brand Loyal Norwegians
Weifa Maintains Lead Thanks To Its Dominance in Key Categories
Gsk Sees Mixed Performance But Benefits From Growth of Topical Analgesics/anaesthetic
Category Data
Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024
Executive Summary
Consumer Health Sees Steady Growth As Norwegians Show Willingness To Invest in Health
Changing Face of Norway Sees Shifts in Demand Within Consumer Health
GlaxoSmithKline and Pfizer Combine To Push Gsk Consumer Healthcare Into the Lead
Distribution Focuses on Convenience, Quality and Availability
An Ageing Population, A Greater Focus on Health and Wellbeing and Climate Change Just Some of the Issues Expected To Drive Growth Over the Forecast Period
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019
Market Data
Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll